絞り込み

16555

広告

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: reply.

著者 Palareti G , Antonucci E , Ageno W , Mastroiacovo D , Poli D , Tosetto A
J Thromb Haemost.2018 Sep 21 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (4view , 0users)

Full Text Sources

We would like to thank Dr Brown and colleagues for the attention they gave to our study on ACCP bleeding score. We have read with interest their communication and share most of their comments. We agree that bleeding risk scores may be used, sometimes inappropriately, to deny anticoagulation for patients perceived at high risk of bleeding. In our opinion, bleeding scores should mainly be used to drive the decision on the duration of anticoagulation beyond the first three months, a treatment period required for all patients with acute venous thromboembolism (VTE), regardless of the individual risk of bleeding. However, the scope of a score is almost completely lost if the "high risk" patients are overestimated, especially if the real rate of bleeding is rather low. This article is protected by copyright. All rights reserved.
PMID: 30240521 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード